FDA approves Boehringer Ingelheim's Cyltezo for inflammatory

The newly approved formulation will be offered as a pre-filled syringe or pre-filled autoinjector.

Related Keywords

Boehringer Ingelheim Biosimilar , Boehringer Ingelheim Cyltezo , Stephen Pagnotta , Drug Administration , Boehringer Ingelheim , Ingelheim Biosimilar , Ochre Bio , Pharmaceutical Technology , Fda , Us Food And Drug Administration , Inflammatory Diseases ,